Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas
- 1 April 2004
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 31 (5) , 362-367
- https://doi.org/10.1111/j.0303-6987.2004.00192.x
Abstract
Background: Hobnail hemangioma (targetoid hemosiderotic hemangioma) is a small benign vascular tumor of the superficial and mid‐dermis. In contrast to its well‐characterized histology, it has been unclear whether this tumor arises from blood vessel endothelial cells (BECs) or lymphatic vessel endothelial cells (LECs).Methods: We analyzed 10 hobnail hemangiomas by immunohistochemistry, using the recently described lymphatic endothelial cell marker, D2‐40. For comparison, CD31, CD34, and α‐smooth muscle actin expression were studied in consecutive sections of the paraffin‐embedded tissues.Results: In all analyzed vessels, D2‐40 labeled exclusively LECs, whereas BECs were consistently negative. In contrast to capillary BECs, either neighboring the tumors or intermingled, neoplastic endothelial cells of all 10 hobnail hemangiomas were strongly labeled by D2‐40.Conclusions: The results suggest a lymphatic origin for hobnail hemangiomas. This view is further supported by the CD34 negativity of endothelial cells and the lack of actin‐labeled pericytes in hobnail hemangiomas, both characteristic of lymphatic vessels. Moreover, our analysis revealed that microshunts between neoplastic lymphatic vascular channels and small blood vessels occur, explaining some features of hobnail hemangiomas, such as aneurysmatic microstructures, erythrocytes within and beneath neoplastic vascular spaces, inflammatory changes, scarring, and interstitial hemosiderin deposits.Keywords
This publication has 21 references indexed in Scilit:
- The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissuesThe FASEB Journal, 2002
- The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculatureGenes & Development, 2002
- Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic EndotheliumJournal of Biological Chemistry, 2001
- Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of AngiosarcomasLaboratory Investigation, 2000
- Papillary Intralymphatic Angioendothelioma (PILA)The American Journal of Surgical Pathology, 1999
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999
- Hobnail HemangiomaThe American Journal of Surgical Pathology, 1999
- Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular TumorsThe American Journal of Pathology, 1998
- Retiform HemangioendotheliomaThe American Journal of Surgical Pathology, 1994
- Targetoid hemosiderotic hemangiomaJournal of the American Academy of Dermatology, 1988